| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |



From the Division of Molecular Pathology of the Department of Pathology,
*
and the Department of Oncology,
Johns Hopkins Hospital, Baltimore; and the Department of Biostatistics,
Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland
Allogeneic bone marrow transplant engraftment assays use polymorphisms in the human genome to determine the relative percentages of donor and recipient cells present in the recipient. We describe a novel posttransplant assay approach using single nucleotide polymorphisms (SNPs), the most common type of polymorphism in humans. Using samples of defined genotype, we used real-time polymerase chain reaction (PCR) and allele-specific fluorescent TaqMan probes to assay a SNP of the cytochrome P450 CYP2C9 gene. Standard curves of chimeric mixes showed a linear relationship between the ratio of two alleles and the ratio of their respective fluorophore emission, except for mixes with a low percentage (<5%) of the less common allele. We validated the SNP real-time PCR assay by comparing it to Southern hybridization analysis, analyzing DNA mixes in a blinded fashion with both methods. The correlation between the two methods was high. We have produced a statistical model that varies allele frequency to predict how many SNPs would be required to produce a functional SNP panel. Additional development will be necessary to produce such a panel of highly informative SNPs for clinical use. A real-time PCR SNP assay may ultimately provide more accurate quantification and shortened turnaround time compared to current post-engraftment assays.
This article has been cited by other articles:
![]() |
S.-L. Liang, M.-T. Lin, M. J. Hafez, C. D. Gocke, K. M. Murphy, L. J. Sokoll, and J. R. Eshleman Application of Traditional Clinical Pathology Quality Control Techniques to Molecular Pathology J. Mol. Diagn., March 1, 2008; 10(2): 142 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hurtle, E. Bode, D. A. Kulesh, R. S. Kaplan, J. Garrison, D. Bridge, M. House, M. S. Frye, B. Loveless, and D. Norwood Detection of the Bacillus anthracis gyrA Gene by Using a Minor Groove Binder Probe J. Clin. Microbiol., January 1, 2004; 42(1): 179 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Cashion, C. J. Driscoll, and O. Sabek Emerging Genetic Technologies in Clinical and Research Settings Biol Res Nurs, January 1, 2004; 5(3): 159 - 167. [Abstract] [PDF] |
||||
![]() |
E. P. Hochberg, D. B. Miklos, D. Neuberg, D. A. Eichner, S. F. McLaughlin, A. Mattes-Ritz, E. P. Alyea, J. H. Antin, R. J. Soiffer, and J. Ritz A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation Blood, January 1, 2003; 101(1): 363 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Borlak and T. Thum Identification of Major CYP2C9 and CYP2C19 Polymorphisms by Fluorescence Resonance Energy Transfer Analysis Clin. Chem., September 1, 2002; 48(9): 1592 - 1594. [Full Text] [PDF] |
||||
![]() |
B. Zimmermann, W. Holzgreve, F. Wenzel, and S. Hahn Novel Real-Time Quantitative PCR Test for Trisomy 21 Clin. Chem., February 1, 2002; 48(2): 362 - 363. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |